<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34857243</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-4577</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical nutrition ESPEN</Title><ISOAbbreviation>Clin Nutr ESPEN</ISOAbbreviation></Journal><ArticleTitle>Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS-CoV-2 post-infection progress.</ArticleTitle><Pagination><StartPage>510</StartPage><EndPage>518</EndPage><MedlinePgn>510-518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnesp.2021.08.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-4577(21)00319-3</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">Recent studies have verified that the SARS-CoV-2 infection (from December 2019 has affected 123 million people throughout the world and more than 3 million people in Italy), can have medium-term and long-term effects, collectively referred to as "post-Covid syndrome" or "long-Covid" characterized by chronic fatigue, followed by muscle weakness, dyspnea and headache. Chronic fatigue or chronic tiredness is a persistent symptom both in patients who have experienced a severe infection and in those who have experienced a mild form of infection. Studies conducted on both patients discharged from hospital and patients managed at home showed that there was no association between the severity of the Coronavirus disease (Covid-19) and the subsequent chronic fatigue symptom. The aim of this study was to evaluate the ability of a nutritional supplement based on vitamins, minerals, amino acids and plant extracts (Apportal&#xae;) intake, to ameliorate the general health status in particular the chronic fatigue symptom in subjects after SARS-CoV-2 negativity.</AbstractText><AbstractText Label="METHODS">Participants were advised to take one sachet daily of Apportal&#xae; for 28 consecutive days. At the beginning (T0), after 14 days (T1) and after 28 days (T2) of supplementation, general fatigue, mental fatigue and Quality of Life indexes were evaluated through specific questionnaires. The assessment of quality of life and health status were measured through the EuroQoL-5D questionnaire, chronic fatigue using the FACIT-Fatigue questionnaire and mental fatigue using the modified Chalder questionnaire.</AbstractText><AbstractText Label="RESULTS">201 subjects were enrolled for the study; results showed a significant improvement in all indexes analyzed after 14 and 28 days of supplementation. The main significant improvement was observed after the first 14 days and it was further confirmed at 28 days as well. The RTE (Relative Treatment Effect) trend about quality of life, health status, FACIT-Fatigue and mental fatigue in the three questionnaires was statistically significant (Wald Statistic, p&#xa0;&lt;&#xa0;0.0001). The data of FACIT-questionnaire showed an improvement of at least 1 unit in 76.62% of subjects after 14 days and in 90.05% of subjects after 28 days. An improvement of 10-unit was found in about one third of subjects after 14 days and in half of the subjects after 28 days.</AbstractText><AbstractText Label="CONCLUSIONS">This study shows that Apportal&#xae; can reduce chronic fatigue and improve quality of life and health status in subjects after SARS-CoV-2 negativity due to the synergistic effect of its components.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rossato</LastName><ForeName>Maria Sole</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Pharmanutra S.p.a., Pisa, Italy. Electronic address: ms.rossato@pharmanutra.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brilli</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Alesco S.r.l., Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze del Farmaco, Universit&#xe0; degli Studi di Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hematology Service, Internal Medicine Division, Regional Hospital "Antonio Cardarelli", Campobasso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantino</LastName><ForeName>Germano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pharmanutra S.p.a., Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr ESPEN</MedlineTA><NlmUniqueID>101654592</NlmUniqueID><ISSNLinking>2405-4577</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic fatigue</Keyword><Keyword MajorTopicYN="N">Long-Covid</Keyword><Keyword MajorTopicYN="N">Nutritional supplement</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of competing interest Maria Sole Rossato and Germano Tarantino are Pharmanutra S.p.a. employees. Elisa Brilli is Alesco S.r.l. employee, a company included in Pharmanutra group. The other Authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34857243</ArticleId><ArticleId IdType="pmc">PMC8420132</ArticleId><ArticleId IdType="doi">10.1016/j.clnesp.2021.08.031</ArticleId><ArticleId IdType="pii">S2405-4577(21)00319-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D., Wootton D., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas N., Broderick G., Fletcher M.A. Biomarkers for chronic fatigue. Brain Behav Immun. 2012;26:1202&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373648</ArticleId><ArticleId IdType="pubmed">22732129</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PloS One. 2020;15(11) Nov 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S., Lindsell C., Billig Rose E., Shapiro N., Files C., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014; United States, March&#x2013;June 2020. Morb Mortal Wkly Rep. 2020; Jul 31;69(30):993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. J&#xa0;Am Med Assoc. 2020; Aug 11;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Scordo K.A., Richmond M., Munro N. Post&#x2013;COVID-19 syndrome: theoretical basis, identification, and management. ACN Advanced Critical Care. 2021;32(2):188&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">33942071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Voit-Bak K., Donate T., Rodionov R.N., Gainetdinov R.R., Tselmin S., et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis? Mol Psychiatr. 2021; Jun 17:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209771</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference><Reference><Citation>Candan S.A., Elibol N., Abdullahi A. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19. Physiother Theory Pract. 2020;36(6):663&#x2013;668. Jun.</Citation><ArticleIdList><ArticleId IdType="pubmed">32419564</ArticleId></ArticleIdList></Reference><Reference><Citation>Inglis J.E., Lin P.J., Kerns S.L., Kleckner I.R., Kleckner A.S., Castillo D.A., et al. Nutritional interventions for treating cancer-related fatigue: a qualitative review. Nutr Canc. 2019;71(1):21&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456409</ArticleId><ArticleId IdType="pubmed">30688088</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira P., Reis A.D., Diniz R.R., Lima F.A., Leite R.D., da Silva M.C.P., et al. Dietary supplements and fatigue in patients with breast cancer: a systematic review. Breast Canc Res Treat. 2018 Oct;171(3):515&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">29915949</ArticleId></ArticleIdList></Reference><Reference><Citation>Na W., Kim J., Kim H., Lee Y., Jeong B., Lee S.P., et al. Evaluation of oral nutritional supplementation in the management of frailty among the elderly at facilities of community care for the elderly. Clin Nutr Res. 2021 Jan;10(1):24&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850817</ArticleId><ArticleId IdType="pubmed">33564650</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestroni G., Bertolotti G. EuroQoL-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis. 2012;78:155&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">23614330</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D., Wilson H., Shalhoub H., Revicki D.A., Cappelleri J.C., Bushmakin A.G., et al. Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritis. J&#xa0;Patient Rep Outcomes. 2019; May 20;3(1):30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527714</ArticleId><ArticleId IdType="pubmed">31111255</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner E., Menzel U., Puri M.L. Rank score test in factorial designs with repeated measures. J&#xa0;Multivariate Anal. 1999;70:286&#x2013;317.</Citation></Reference><Reference><Citation>IMPATTO DELL&#x2019;EPIDEMIA COVID-19 sulla mortalit&#xe0; totale della POPOLAZIONE RESIDENTE PERIODO GENNAIO-novembre 2020. Rapporto ISTAT 30 December 2020.</Citation></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., Binda F., Zuglian G., Imeri G., et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021;149:e32. Jan 19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardy A.L., Pouteau E., Marquez D., Yilmaz C., Scholey A. Vitamins and minerals for energy, fatigue and cognition: a narrative review of the biochemical and clinical evidence. Nutrients. 2020 Jan 16;12(1):228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7019700</ArticleId><ArticleId IdType="pubmed">31963141</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Nutrition, immunity and COVID-19. BMJ Nutr Prev Health. 2020; May 20;3(1):74&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295866</ArticleId><ArticleId IdType="pubmed">33230497</ArticleId></ArticleIdList></Reference><Reference><Citation>EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to vitamin C, magnesium, iron, niacin and reduction of tiredness and fatigue. EFSA Journal. 2010;8(10):1740-1807&#x2013;1757-1815.</Citation></Reference><Reference><Citation>Ogawa-Ochiai K., Kawasaki K. Panax ginseng for frailty-related disorders: a review. Front Nutr. 2019;5:140. Jan 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344463</ArticleId><ArticleId IdType="pubmed">30705884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Kim H., Lee D., Son C. Oxidative stress is a convincing contributor to idiopathic chronic fatigue. Sci Rep. 2018; Aug 27;8(1):12890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6110864</ArticleId><ArticleId IdType="pubmed">30150620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>